In the present study, we found that FGF21 administration increased the number of CD34+/VEGFR2+ EPCs in the peripheral blood of STZ‐induced T1DM mice at day 3 post‐HLI (Figure 3A,B). The gene discussed is CD34; the disease is type 1 diabetes mellitus.